Geraldine Paulus

Geraldine Paulus

Company: Crossbow Technology Inc

Job title: VP of Corporate Development and Operations


CBX-250: A First-in-Class TCR-Mimetic-Based T-Cell Engager for the Treatment of Myeloid Leukemia 4:05 pm

Introduce a novel TCR-mimetic based T-cell engager against a novel target in AML and other myeloid malignancies Discuss the preclinical characterization strategy and results of target safety, binder potency, binder specificity and TCE developabilityRead more

day: Conference Day Two

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.